Justia Intellectual Property Opinion Summaries
Spigen Korea Co., Ltd. v. Ultraproof, Inc.
The Spigen Design Patents each claim a case for a cellular phone. In an infringement case, the district court held as a matter of law that the Spigen Design Patents were obvious over the 218 and 209 patents and granted summary judgment of invalidity in favor of Ultraproof. Subsequently, Ultraproof moved for attorneys’ fees under 35 U.S.C. 285. The district court denied the motion. The Federal Circuit reversed with respect to invalidity; the district court improperly resolved a genuine dispute of material fact. The district court found that despite “slight differences,” the 218 patent undisputedly was “basically the same” as the Spigen Design Patents, and, thus, a proper primary reference. That determination was error because, based on the competing evidence before the district court, a reasonable fact-finder could find otherwise. View "Spigen Korea Co., Ltd. v. Ultraproof, Inc." on Justia Law
Webster v. Guitars
Plaintiff, a successful guitar maker and technician, designed a lightning storm graphic that originally appeared on the guitar of Darrell Abbott, late guitarist of the heavy-metal band Pantera. This copyright registration action relates to the lightning storm graphic. Plaintiff filed suit against defendant and several others, alleging copyright infringement, unfair competition, and false endorsement.The Eleventh Circuit affirmed the district court's grant of summary judgment in favor of defendants, holding that the district court properly concluded that plaintiff's copyright claim, primarily concerning copyright ownership, was time-barred; the district court correctly granted summary judgment in favor of defendants on plaintiff's false advertising and unfair competition claims because the statements he relies on were not false or misleading; and the district court properly granted summary judgment in favor of defendants on plaintiff's false endorsement claim, because plaintiff failed to establish a likelihood of consumer confusion, mistake, or deception. View "Webster v. Guitars" on Justia Law
Stratus Networks, Inc. v. UBTA-UBET Communications Inc.
In 2012, Stratus, a facilities-based telecommunications provider, applied to register the STRATUS mark. UBTA, also a telecommunications provider, owns the STRATA mark and opposed registration of the STRATUS mark on grounds of a likelihood of confusion with UBTA’s STRATA mark. The Trademark Trial and Appeal Board found a likelihood of confusion and refused registration of the STRATUS mark, 15 U.S.C. 1052. The Board concluded that six of the 13 “DuPont factors” were relevant and that two factors “weigh heavily in favor” of finding a likelihood of confusion, one factor “weighs in favor” of finding a likelihood of confusion, two factors are neutral, and one factor weighs “slightly” against finding a likelihood of confusion. The Federal Circuit affirmed the determination as supported by substantial evidence and is not otherwise legally erroneous. While the Board is required to consider each DuPont factor for which it has evidence, it may focus its analysis on dispositive factors, such as similarity of the marks and relatedness of the goods. The Board determined that “even careful purchasers are likely to be confused by similar marks used in connection with services that are, in part, legally identical.” View "Stratus Networks, Inc. v. UBTA-UBET Communications Inc." on Justia Law
Ericsson Inc. v. TCL Communication Technology Holdings, Ltd.
Ericsson sued TCL for infringement of its patent, titled “Security Access Manager in Middleware,” describing “a system and method for controlling access to a platform for a mobile terminal for a wireless telecommunications system.” Ericsson argued that TCL infringed claims 1 and 5 by making and selling smartphones that include the Android operating system, including “a security system that can grant apps access to a subset of services on the phone, with the end-user controlling the permissions granted to each app.” The jury found those claims infringed, awarded damages and found that TCL’s infringement was willful.The Federal Circuit reversed, finding that the patent claims ineligible subject matter under 35 U.S.C. 101. Claims 1 and 5 are directed to the abstract idea of controlling access to or limiting permission to, resources. Although written in technical jargon, a close analysis of the claims reveals that they require nothing more than this abstract idea. The claims are silent as to how access is controlled. They merely make generic functional recitations that requests are made and then granted. Neither claim recites any particular architecture; there is nothing sufficient to turn the claim into anything more than a generic computer for performing the abstract idea of controlling access to resources. View "Ericsson Inc. v. TCL Communication Technology Holdings, Ltd." on Justia Law
O.F. Mossberg & Sons, Inc. v. Timney Triggers, LLC
After licensing negotiations with Timney failed, Mossberg sued Timney for patent infringement. Instead of answering the complaint, Timney filed for inter partes reexamination. The district court granted a stay. The Patent Office rejected certain claims. Mossberg canceled the rejected claims and added new claims. Before the inter partes reexamination proceeded further, the Patent Office vacated its institution decision because Timney had not identified the real party in interest in its petition. In 2014-2015, Timney filed three ex parte reexamination requests. The examiner ultimately rejected all pending claims over prior art. The Patent Trial and Appeal Board affirmed. Throughout these reexaminations, the district court maintained the stay despite several motions by Mossberg to lift it.Mossberg filed a notice of voluntary dismissal under Rule 41(a)(1)(A)(i). The district court entered a docket text order stating that the case was dismissed without prejudice under Rule 41(a)(1)(A)(i). Timney moved to declare the case exceptional so that it could pursue attorney’s fees, 35 U.S.C. 285. The Federal Circuit affirmed the denial of the motion. Timney was not a “prevailing party” because a Rule 41 dismissal without prejudice is not a decision on the merits and thus cannot be a judicial declaration altering the legal relationship between the parties. View "O.F. Mossberg & Sons, Inc. v. Timney Triggers, LLC" on Justia Law
Golden v. United States
Golden, pro se, filed this suit in 2019, under the Tucker Act, 28 U.S.C. 1491(a), seeking “reasonable and entire compensation for the unlicensed use and manufacture” of his “inventions described in and covered by” various patents. He had filed an unsuccessful patent infringement suit against the government in 2013; a fifth amended complaint had alleged “Fifth Amendment Takings.” In 2014, the government sought inter partes review (IPR) of the patents; Golden is challenging an unfavorable decision as “ultra vires.” The Claims Court dismissed Golden’s 2019 complaint as largely duplicative of the 2013 suit.The Federal Circuit affirmed. The Claims Court did not have jurisdiction over these section 1491 claims because patent infringement claims against the government are to be pursued exclusively under 28 U.S.C. 1498. A patent owner may not pursue an infringement action as a taking under the Fifth Amendment. With respect to claims arising from the IPR proceedings, the court noted that Golden voluntarily filed a non-contingent motion to amend the claims on which the IPR was instituted. His substitute claims were found unpatentable. The claims at issue were canceled as result of Golden’s own voluntary actions; cancellation of the claims in the government-initiated IPR cannot, therefore, be chargeable to the government under any legal theory. View "Golden v. United States" on Justia Law
Bozeman Financial LLC v. Federal Reserve Bank
The Patent Trial and Appeal Board conducted covered business method (CBM) review and found all of the claims of Bozeman’s patents, directed to methods for authorizing and clearing financial transactions to detect and prevent fraud, ineligible under 35 U.S.C. 101.1. Bozeman challenged the Board’s authority to decide the petitions, arguing that the Federal Reserve Banks are not “persons” under the America Invents Act (AIA).The Federal Circuit affirmed, holding that the Banks are “persons” who may petition for post-issuance review under the AIA. While the Supreme Court has held that federal agencies are not “persons” able to seek post-issuance review of a patent under the AIA, the Banks are distinct from the government for purposes of the AIA. They are operating members of the nation’s Federal Reserve System, which is a federal agency, but they are not government-owned and are operationally distinct from the federal government. The claims at issue are directed to the abstract idea of “collecting and analyzing information for financial transaction fraud or error detection” and do not contain an inventive concept sufficient to “transform the nature of the claims into patent-eligible applications of an abstract idea.” View "Bozeman Financial LLC v. Federal Reserve Bank" on Justia Law
Illinois Tool Works, Inc. v. Rust-Oleum Corp.
Illinois Tool Works, maker of Rain-X, filed suit against Rust-Oleum over a commercial for its competing product, RainBrella. Illinois Tool Works alleged that the commercial made three false claims. After a jury ruled in favor of Illinois Tool Works, it awarded the company over $1.3 million. The district court then reduced the corrective-advertising award.The Fifth Circuit held that Illinois Tool Works failed to present sufficient evidence showing that Rust-Oleum's profits were attributable to the Lanham Act violation. Therefore, the court vacated the disgorgement-of-profits award, holding that there was no causal connection between Rust-Oleum's false advertising and its profits. The court never explicitly condoned a prospective corrective-advertising award, but saw no principled reason to prohibit them categorically. In this case, because Illinois Tool Works offered no evidence to support the corrective-advertising award, the court held that a jury could not have reasonably awarded any amount to Illinois Tool Works. Finally, the court held that the evidence was insufficient to support the district court's injunction against Rust-Oleum for making the 100-car-washes claim.Therefore, the district court erred in denying Rust-Oleum's renewed motion for judgment as a matter of law. The court vacated the damages award and reversed the district court's judgment enjoining Rust-Oleum from making its 100-car-washes claim. The court affirmed the district court's judgment enjoining Rust-Oleum from making the other advertising claims. View "Illinois Tool Works, Inc. v. Rust-Oleum Corp." on Justia Law
Amgen Inc. v. Health Care Services
This case arose when Amgen submitted a price increase notice to CCHCS and other registered purchasers. Reuters News made a request under the California Public Records Act, seeking the price increase notices. Amgen then filed a petition for writ of mandamus blocking disclosure. Amgen also moved for a preliminary injunction, which the trial court granted. While this appeal was pending, the trial court sustained CCHCS's demurrer to the mandamus cause of action with leave to amend, and then Amgen chose to dismiss the action instead.The Court of Appeal held that the appeal was not barred by the mootness doctrine where the issues raised are capable of repetition because there will be future price increase notices. Furthermore, the issues are likely to evade review because a pharmaceutical manufacturer has little reason to continue to prosecute a mandamus action after obtaining a preliminary injunction for the 60-day period before a price increase becomes public.On the merits, the court held that the trial court abused its discretion by concluding that Amgen had sufficiently shown that its price increase notice pursuant to Senate Bill No. 17 was a trade secret despite its disclosure to the registered purchasers. In this case, Amgen failed to explain how its purported trade secret maintained its confidentiality and concomitant value to Amgen when it was disclosed to over 170 purchasers who had the incentive to use the information to their benefit and Amgen's detriment, and were not subject to any restrictions on using or further disseminating the information. Likewise, the court held that the trial court abused its discretion in finding that the balance of harms favored Amgen. Therefore, the court reversed the trial court's order granting a preliminary injunction in favor of Amgen. View "Amgen Inc. v. Health Care Services" on Justia Law
Nevro Corp. v. Boston Scientific Corp.
Nevro sued, alleging infringement of 18 claims across seven patents that are directed to high-frequency spinal cord stimulation therapy for inhibiting pain. Conventional spinal cord stimulation systems deliver electrical pulses to the spinal cord to generate sensations, such as tingling or paresthesia, that mask or otherwise alter the patient’s pain. The claimed invention purportedly improves conventional spinal cord stimulation therapy by using waveforms with high-frequency elements or components, which are intended to reduce or eliminate side effects. The district court issued a joint claim construction and summary judgment order, holding certain claims invalid as indefinite. As to the remaining six claims, found not indefinite, the court granted summary judgment of noninfringement.The Federal Circuit vacated and remanded. The district court erred in holding invalid as indefinite the “paresthesia-free” system and device terms and in holding indefinite the claims reciting the term “configured to.” The Federal Circuit construed “configured to” to mean “programmed to” and construed “means for generating” as a means-plus-function term, having a function of “generating” and a structure of “a signal/pulse generator configured to generate” the claimed signals. The district court erred in its claim construction but correctly determined that the term “therapy signal” does not render the claims indefinite; a “therapy signal” is “a spinal cord stimulation or modulation signal to treat pain.” View "Nevro Corp. v. Boston Scientific Corp." on Justia Law